EMILY ROECKER: Open Payments
NPI 1114552312 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 52 payments from 14 companies in 2025. Trend: 2023 $154 · 2024 $168 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $368 |
| Novo Nordisk Inc | 6 | $184 |
| Xeris Pharmaceuticals, Inc. | 6 | $182 |
| Otsuka America Pharmaceutical, Inc. | 3 | $149 |
| ABBVIE INC. | 5 | $85 |
| Lilly USA, LLC | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 5 | $57 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| SHIELD THERAPEUTICS INC | 2 | $47 |
| Mannkind Corporation | 1 | $25 |
Products named: Korlym, RECORLEV, REXULTI, Ozempic, MOUNJARO, Wegovy, VOQUEZNA, Auvelity.
Industry payments across OK — which companies pay providers there.
